Dr. Reddy's, Glaxo Settle Imitrex Patent Dispute
India-based drug company Dr. Reddy’s said on Tuesday that it plans to distribute an authorized generic version of sumatriptan succinate in 25mg, 50mg and 100mg tablets.
The expected launch date in late 2008 precedes the expiration of the Imitrex patents on Feb. 6, 2009.
Other terms of the settlement agreement were not disclosed, and the agreement is...
To view the full article, register now.